Double-Blind, Placebo-Controlled, Dose-Escalating Study Evaluating the Safety and Immunogenicity of an Epitope-Specific Chemically Defined Nanoparticle RSV Vaccine.
Vaccines（2023）
摘要
V-306 was safe and well-tolerated. Future modifications of the vaccine and assay conditions will likely improve the results of vaccination.
更多查看译文
关键词
FsIIm epitope,RSV,healthy volunteers,immunogenicity,intramuscular,phase I,respiratory syncytial virus,safety,vaccine
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要